Potentiation of anti-tumor immune effects by PARP Inhibitors

被引：0
|
作者：
Chabanon, R. [1 ]
Muirhead, G. [2 ]
Krastev, D. [2 ]
Adam, J. [3 ]
Garrido, M. [4 ]
Morel, D. [1 ]
Dorvault, N. [1 ]
Pettitt, S. [2 ]
Tutt, A. N. J. [5 ]
Marabelle, A. [6 ]
Soria, J. C. [6 ]
Lord, C. J. [2 ,5 ]
Postel-Vinay, S. [7 ]
机构：
[1] Gustave Roussy, U981 Inserm Atip Avenir, Villejuif, France
[2] Inst Canc Res, Cruk Gene Funct Lab, London, England
[3] Gustave Roussy, Dept Pathol, Villejuif, France
[4] Gustave Roussy, U981 Inserm, Villejuif, France
[5] Inst Canc Res, Breast Canc Now Res Unit, London, England
[6] Gustave Roussy, Drug Dev Dept, Villejuif, France
[7] Gustave Roussy, Drug Dev Dept, Inserm U981, Villejuif, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-0258
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [31] Anti-tumor activities of farnesyltransferase inhibitors
    Kohl, NE
    Anthony, NJ
    Conner, MW
    deSolms, SJ
    Gibbs, JB
    Graham, L
    Hartman, GD
    Koblan, KS
    Omer, CA
    Pellicer, A
    Williams, TM
    Windle, JJ
    Oliff, A
    [J]. FASEB JOURNAL, 1997, 11 (09): : A993 - A993
  • [32] Wnt antagonists synergize with immune checkpoint inhibitors to enhance anti-tumor responses
    Ross, Jenny
    Hoey, Timothy
    Kapoun, Ann
    Lewicki, John
    Gurney, Austin
    Murriel, Christopher L.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [33] Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment
    Allavena, Paola
    Belgiovine, Cristina
    Digifico, Elisabeth
    Frapolli, Roberta
    D'Incalci, Maurizio
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Lymphangiogenesis and Anti-Tumor Immune Responses
    Varney, Michelle L.
    Singh, Seema
    Backora, Matthew
    Chen, Zhengtang
    Singh, Rakesh K.
    [J]. CURRENT MOLECULAR MEDICINE, 2009, 9 (06) : 694 - 701
  • [35] Minimizes T cells DNA damage induced by PARP inhibitors and enhances its anti-tumor efficacy
    Liu, Jiahao
    Jiao, Xiaofei
    Mu, Wei
    Li, Huayi
    Zhu, Li
    Zhao, Xuejiao
    Mills, Gordon B.
    Gao, Qinglei
    Fang, Yong
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [36] Nanocatalytic Anti-Tumor Immune Regulation
    Li, Mingyuan
    Jiang, Han
    Hu, Ping
    Shi, Jianlin
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024, 63 (13)
  • [37] Induction of autophagy does not alter the anti-tumor effects of HDAC inhibitors
    A Newbold
    S J Vervoort
    B P Martin
    M Bots
    R W Johnstone
    [J]. Cell Death & Disease, 2012, 3 : e387 - e387
  • [38] Induction of autophagy does not alter the anti-tumor effects of HDAC inhibitors
    Newbold, A.
    Vervoort, S. J.
    Martin, B. P.
    Bots, M.
    Johnstone, R. W.
    [J]. CELL DEATH & DISEASE, 2012, 3 : e387 - e387
  • [39] Cutaneous side effects of anti-tumor therapy with BRAF and MEK inhibitors
    Gutzmer, R.
    Hassel, J. C.
    Kaehler, K. C.
    Loquai, C.
    Moessner, R.
    Ugurel, S.
    Zimmer, L.
    [J]. HAUTARZT, 2014, 65 (07): : 582 - +
  • [40] Dual antitumor immunomodulatory effects of PARP inhibitor on the tumor microenvironment: A counterbalance between anti-tumor and pro-tumor
    Yi, Xiao-Fang
    Gao, Ruo-Lin
    Sun, Li
    Wu, Zhi-Xuan
    Zhang, Shu-Ling
    Huang, Le-Tian
    Han, Cheng-Bo
    Ma, Jie-Tao
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 163
12345